Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Retinopathy | 30 | 2024 | 108 | 10.580 |
Why?
|
Retinal Vessels | 21 | 2021 | 71 | 4.970 |
Why?
|
Retina | 33 | 2024 | 422 | 4.660 |
Why?
|
Diabetes Mellitus, Experimental | 20 | 2024 | 96 | 3.590 |
Why?
|
Endothelial Cells | 15 | 2024 | 331 | 3.230 |
Why?
|
Sphingomyelin Phosphodiesterase | 8 | 2020 | 13 | 2.150 |
Why?
|
Ceramides | 6 | 2024 | 24 | 1.930 |
Why?
|
Docosahexaenoic Acids | 7 | 2018 | 91 | 1.530 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 213 | 1.510 |
Why?
|
Animals | 56 | 2024 | 10093 | 1.460 |
Why?
|
Tight Junctions | 3 | 2023 | 29 | 1.420 |
Why?
|
Circadian Rhythm | 9 | 2020 | 76 | 1.380 |
Why?
|
Complement Activation | 2 | 2020 | 25 | 1.270 |
Why?
|
Rats | 25 | 2024 | 1554 | 1.220 |
Why?
|
Mice | 33 | 2024 | 4478 | 1.110 |
Why?
|
Hyperglycemia | 4 | 2014 | 78 | 1.090 |
Why?
|
Endothelium, Vascular | 6 | 2010 | 305 | 1.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 144 | 1.010 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 626 | 0.990 |
Why?
|
Cholesterol | 8 | 2023 | 182 | 0.980 |
Why?
|
Blood-Retinal Barrier | 4 | 2020 | 27 | 0.900 |
Why?
|
Bone Marrow | 7 | 2020 | 76 | 0.890 |
Why?
|
Lipid Metabolism | 4 | 2020 | 122 | 0.890 |
Why?
|
Fasting | 3 | 2021 | 80 | 0.870 |
Why?
|
alpha-Cyclodextrins | 1 | 2023 | 3 | 0.860 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 325 | 0.850 |
Why?
|
Capillary Permeability | 4 | 2018 | 38 | 0.850 |
Why?
|
Oxysterols | 1 | 2023 | 3 | 0.830 |
Why?
|
Immunotherapy | 1 | 2024 | 143 | 0.810 |
Why?
|
Aldehyde Reductase | 4 | 2014 | 7 | 0.810 |
Why?
|
Cytokines | 5 | 2013 | 441 | 0.810 |
Why?
|
Diabetic Angiopathies | 2 | 2021 | 48 | 0.780 |
Why?
|
MicroRNAs | 3 | 2016 | 281 | 0.770 |
Why?
|
RNA, Messenger | 12 | 2023 | 648 | 0.760 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 58 | 0.750 |
Why?
|
Eye Proteins | 3 | 2018 | 197 | 0.750 |
Why?
|
Disease Models, Animal | 15 | 2023 | 1406 | 0.740 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2021 | 11 | 0.730 |
Why?
|
Microvessels | 3 | 2018 | 86 | 0.730 |
Why?
|
Cells, Cultured | 14 | 2021 | 978 | 0.720 |
Why?
|
Male | 31 | 2024 | 13040 | 0.720 |
Why?
|
Retinal Neovascularization | 3 | 2018 | 20 | 0.720 |
Why?
|
Interleukin-1beta | 6 | 2024 | 43 | 0.700 |
Why?
|
Glucose | 8 | 2008 | 199 | 0.690 |
Why?
|
Phospholipids | 3 | 2017 | 75 | 0.690 |
Why?
|
Complement Membrane Attack Complex | 1 | 2020 | 16 | 0.680 |
Why?
|
Pigment Epithelium of Eye | 3 | 2008 | 15 | 0.670 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 1498 | 0.660 |
Why?
|
Bone Marrow Cells | 3 | 2020 | 80 | 0.660 |
Why?
|
Lipids | 4 | 2022 | 199 | 0.660 |
Why?
|
Extracellular Vesicles | 1 | 2020 | 36 | 0.650 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2017 | 93 | 0.650 |
Why?
|
Humans | 39 | 2024 | 27160 | 0.640 |
Why?
|
Tandem Mass Spectrometry | 4 | 2023 | 113 | 0.640 |
Why?
|
Transfection | 3 | 2015 | 314 | 0.610 |
Why?
|
Intercellular Adhesion Molecule-1 | 5 | 2014 | 58 | 0.600 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2018 | 177 | 0.590 |
Why?
|
Inflammation | 4 | 2020 | 608 | 0.580 |
Why?
|
CLOCK Proteins | 3 | 2014 | 3 | 0.570 |
Why?
|
Membrane Fluidity | 1 | 2017 | 5 | 0.560 |
Why?
|
Gene Expression Profiling | 7 | 2016 | 440 | 0.550 |
Why?
|
Signal Transduction | 6 | 2021 | 1379 | 0.550 |
Why?
|
Dyslipidemias | 1 | 2017 | 31 | 0.550 |
Why?
|
Blotting, Western | 10 | 2017 | 506 | 0.540 |
Why?
|
Membrane Proteins | 2 | 2018 | 469 | 0.540 |
Why?
|
Cattle | 5 | 2023 | 383 | 0.530 |
Why?
|
Immunoglobulin G | 1 | 2018 | 267 | 0.530 |
Why?
|
Exosomes | 1 | 2018 | 92 | 0.530 |
Why?
|
Lactic Acid | 2 | 2015 | 89 | 0.510 |
Why?
|
Wnt3A Protein | 1 | 2015 | 6 | 0.490 |
Why?
|
Corneal Neovascularization | 1 | 2015 | 3 | 0.490 |
Why?
|
Receptors, LDL | 1 | 2015 | 28 | 0.480 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2014 | 65 | 0.480 |
Why?
|
Polyglycolic Acid | 1 | 2015 | 36 | 0.480 |
Why?
|
Cornea | 1 | 2015 | 65 | 0.470 |
Why?
|
Rats, Sprague-Dawley | 11 | 2020 | 546 | 0.470 |
Why?
|
Stem Cells | 2 | 2013 | 113 | 0.470 |
Why?
|
Wnt Signaling Pathway | 1 | 2015 | 54 | 0.470 |
Why?
|
Retinitis | 1 | 2014 | 8 | 0.460 |
Why?
|
Acetyltransferases | 3 | 2009 | 36 | 0.450 |
Why?
|
Early Growth Response Protein 1 | 1 | 2014 | 9 | 0.450 |
Why?
|
Macular Degeneration | 3 | 2022 | 79 | 0.440 |
Why?
|
Neonatal Screening | 4 | 2016 | 12 | 0.410 |
Why?
|
Liver X Receptors | 4 | 2021 | 21 | 0.410 |
Why?
|
Capillaries | 2 | 2017 | 32 | 0.410 |
Why?
|
Hematopoietic Stem Cells | 5 | 2017 | 58 | 0.400 |
Why?
|
Mice, Knockout | 5 | 2024 | 795 | 0.400 |
Why?
|
Retinal Pigment Epithelium | 3 | 2020 | 91 | 0.390 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2024 | 243 | 0.390 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2010 | 20 | 0.380 |
Why?
|
Sirtuin 1 | 3 | 2023 | 40 | 0.370 |
Why?
|
Nanoparticles | 1 | 2015 | 276 | 0.370 |
Why?
|
Cell Death | 3 | 2021 | 111 | 0.370 |
Why?
|
Diabetic Neuropathies | 2 | 2009 | 14 | 0.350 |
Why?
|
Cell Adhesion Molecules | 3 | 2009 | 64 | 0.340 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2023 | 128 | 0.340 |
Why?
|
Microglia | 3 | 2018 | 58 | 0.300 |
Why?
|
Wound Infection | 2 | 2017 | 13 | 0.290 |
Why?
|
Pseudomonas Infections | 2 | 2017 | 24 | 0.280 |
Why?
|
Fatty Acids | 4 | 2023 | 202 | 0.280 |
Why?
|
Gene Expression | 2 | 2021 | 408 | 0.280 |
Why?
|
Caveolae | 1 | 2007 | 8 | 0.270 |
Why?
|
Disease Progression | 3 | 2018 | 458 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2017 | 123 | 0.270 |
Why?
|
Membrane Microdomains | 1 | 2007 | 36 | 0.270 |
Why?
|
Reactive Oxygen Species | 1 | 2008 | 281 | 0.260 |
Why?
|
Monocytes | 3 | 2016 | 133 | 0.260 |
Why?
|
Biofilms | 2 | 2017 | 119 | 0.260 |
Why?
|
Female | 15 | 2024 | 14661 | 0.250 |
Why?
|
Retinal Rod Photoreceptor Cells | 2 | 2018 | 91 | 0.250 |
Why?
|
Retinal Cone Photoreceptor Cells | 2 | 2018 | 115 | 0.240 |
Why?
|
Vitreous Body | 1 | 2024 | 22 | 0.230 |
Why?
|
Retinopathy of Prematurity | 2 | 2018 | 37 | 0.220 |
Why?
|
Cell Movement | 4 | 2016 | 353 | 0.220 |
Why?
|
Centrifugation, Density Gradient | 2 | 2018 | 26 | 0.220 |
Why?
|
Hyperlipidemias | 1 | 2003 | 36 | 0.220 |
Why?
|
Mice, Transgenic | 3 | 2021 | 489 | 0.210 |
Why?
|
Cytoskeleton | 2 | 2017 | 40 | 0.210 |
Why?
|
Cholesterol 24-Hydroxylase | 2 | 2022 | 2 | 0.210 |
Why?
|
Sterols | 1 | 2023 | 3 | 0.210 |
Why?
|
Interleukin-6 | 3 | 2020 | 189 | 0.200 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 75 | 0.200 |
Why?
|
Liver | 6 | 2014 | 424 | 0.200 |
Why?
|
Swine | 1 | 2023 | 221 | 0.200 |
Why?
|
Cerebral Palsy | 2 | 2012 | 31 | 0.200 |
Why?
|
Fibric Acids | 1 | 2022 | 2 | 0.200 |
Why?
|
Mitochondria | 2 | 2020 | 342 | 0.200 |
Why?
|
Biomarkers | 2 | 2018 | 738 | 0.200 |
Why?
|
Monosaccharide Transport Proteins | 4 | 2003 | 23 | 0.190 |
Why?
|
Retinal Neurons | 1 | 2021 | 13 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 15 | 0.180 |
Why?
|
Blood Specimen Collection | 2 | 2012 | 14 | 0.180 |
Why?
|
Cholic Acids | 1 | 2020 | 1 | 0.180 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2007 | 165 | 0.180 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2018 | 80 | 0.180 |
Why?
|
Apoptosis | 1 | 2024 | 740 | 0.180 |
Why?
|
Pancreas | 3 | 2000 | 59 | 0.170 |
Why?
|
Chronobiology Disorders | 1 | 2020 | 1 | 0.170 |
Why?
|
Complement C1 | 1 | 2020 | 3 | 0.170 |
Why?
|
Green Fluorescent Proteins | 3 | 2016 | 100 | 0.170 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 106 | 0.170 |
Why?
|
Nitric Oxide | 3 | 2012 | 152 | 0.170 |
Why?
|
Immunoglobulins | 1 | 2020 | 33 | 0.170 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2017 | 129 | 0.170 |
Why?
|
Cell Survival | 2 | 2020 | 396 | 0.170 |
Why?
|
Fatty Acid Desaturases | 3 | 2010 | 15 | 0.170 |
Why?
|
Wound Healing | 2 | 2017 | 113 | 0.170 |
Why?
|
Diabetes Complications | 1 | 2020 | 66 | 0.170 |
Why?
|
Autophagy | 1 | 2020 | 72 | 0.160 |
Why?
|
Ultracentrifugation | 1 | 2018 | 8 | 0.150 |
Why?
|
Dysbiosis | 1 | 2018 | 15 | 0.150 |
Why?
|
Rats, Long-Evans | 2 | 2017 | 35 | 0.150 |
Why?
|
Complement System Proteins | 1 | 2018 | 24 | 0.150 |
Why?
|
Claudin-5 | 1 | 2018 | 1 | 0.150 |
Why?
|
Occludin | 1 | 2018 | 12 | 0.150 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2018 | 17 | 0.150 |
Why?
|
Dipeptides | 1 | 2018 | 22 | 0.150 |
Why?
|
Stem Cell Niche | 1 | 2017 | 11 | 0.150 |
Why?
|
Drug Discovery | 1 | 2018 | 32 | 0.150 |
Why?
|
Pancreatic Ducts | 1 | 1997 | 10 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 589 | 0.140 |
Why?
|
Suprachiasmatic Nucleus | 2 | 2014 | 3 | 0.140 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2017 | 2 | 0.140 |
Why?
|
ARNTL Transcription Factors | 1 | 2017 | 2 | 0.140 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 163 | 0.140 |
Why?
|
Neointima | 1 | 2017 | 4 | 0.140 |
Why?
|
Antigens, CD34 | 1 | 2017 | 13 | 0.140 |
Why?
|
Reperfusion Injury | 1 | 2017 | 31 | 0.140 |
Why?
|
Ependymoglial Cells | 1 | 2017 | 29 | 0.140 |
Why?
|
Chromaffin Cells | 1 | 1996 | 2 | 0.140 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1996 | 23 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 2016 | 33 | 0.130 |
Why?
|
Specimen Handling | 1 | 2016 | 30 | 0.130 |
Why?
|
Calcium | 2 | 1996 | 232 | 0.130 |
Why?
|
Gastrointestinal Microbiome | 1 | 2018 | 122 | 0.130 |
Why?
|
Chimera | 1 | 2016 | 3 | 0.130 |
Why?
|
RNA Interference | 1 | 2016 | 135 | 0.130 |
Why?
|
Sphingolipids | 1 | 2016 | 20 | 0.130 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 15 | 0.130 |
Why?
|
Cell Count | 1 | 2016 | 85 | 0.130 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 42 | 0.130 |
Why?
|
Cell Membrane | 1 | 2017 | 236 | 0.120 |
Why?
|
Mass Spectrometry | 2 | 2014 | 188 | 0.120 |
Why?
|
Rats, Wistar | 3 | 2013 | 149 | 0.120 |
Why?
|
Spleen | 1 | 2016 | 109 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 262 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 190 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 156 | 0.120 |
Why?
|
Blood Glucose | 2 | 2009 | 307 | 0.120 |
Why?
|
Up-Regulation | 1 | 2015 | 241 | 0.120 |
Why?
|
Middle Aged | 5 | 2017 | 6913 | 0.120 |
Why?
|
Liquid-Liquid Extraction | 1 | 2014 | 3 | 0.120 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2014 | 14 | 0.110 |
Why?
|
Down-Regulation | 2 | 2017 | 198 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2016 | 142 | 0.110 |
Why?
|
Dexamethasone | 1 | 2014 | 54 | 0.110 |
Why?
|
Ribonuclease III | 1 | 2013 | 6 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 1993 | 36 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2014 | 114 | 0.110 |
Why?
|
Central Nervous System | 1 | 2013 | 36 | 0.110 |
Why?
|
Imidazoles | 1 | 1993 | 60 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 26 | 0.110 |
Why?
|
Sympathetic Nervous System | 2 | 2013 | 67 | 0.110 |
Why?
|
Dried Blood Spot Testing | 1 | 2012 | 2 | 0.100 |
Why?
|
Period Circadian Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
Aged | 3 | 2018 | 5231 | 0.100 |
Why?
|
Genetic Testing | 1 | 2012 | 64 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2016 | 846 | 0.100 |
Why?
|
Obesity | 2 | 2009 | 654 | 0.100 |
Why?
|
Microfilament Proteins | 2 | 2009 | 28 | 0.100 |
Why?
|
Immunoblotting | 2 | 2003 | 123 | 0.090 |
Why?
|
Caspases | 2 | 2008 | 43 | 0.090 |
Why?
|
Blotting, Northern | 2 | 2002 | 46 | 0.090 |
Why?
|
Leptin | 2 | 2009 | 67 | 0.090 |
Why?
|
Phosphoproteins | 2 | 2009 | 116 | 0.090 |
Why?
|
Leukocytes | 2 | 2018 | 68 | 0.090 |
Why?
|
Caenorhabditis elegans | 1 | 2010 | 58 | 0.090 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2010 | 55 | 0.080 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2010 | 35 | 0.080 |
Why?
|
Norepinephrine | 1 | 2009 | 32 | 0.080 |
Why?
|
Denervation | 1 | 2009 | 10 | 0.080 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 71 | 0.080 |
Why?
|
Gene Silencing | 1 | 2010 | 64 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2017 | 55 | 0.080 |
Why?
|
Phosphatidylethanolamines | 1 | 2009 | 23 | 0.080 |
Why?
|
Weight Gain | 1 | 2009 | 73 | 0.080 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2008 | 5 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 130 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 325 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 195 | 0.080 |
Why?
|
Neuroglia | 1 | 2008 | 30 | 0.080 |
Why?
|
NF-kappa B | 2 | 2009 | 188 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2010 | 164 | 0.080 |
Why?
|
Electromagnetic Phenomena | 1 | 2008 | 15 | 0.070 |
Why?
|
Carbon Monoxide | 1 | 2008 | 47 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2008 | 135 | 0.070 |
Why?
|
Annexin A5 | 1 | 2008 | 24 | 0.070 |
Why?
|
Phosphorylation | 2 | 2008 | 568 | 0.070 |
Why?
|
Superoxides | 1 | 2008 | 62 | 0.070 |
Why?
|
Gene Deletion | 3 | 2017 | 116 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2009 | 133 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2009 | 116 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 115 | 0.070 |
Why?
|
Fura-2 | 3 | 1996 | 10 | 0.070 |
Why?
|
Subcellular Fractions | 1 | 2007 | 20 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2007 | 9 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 2 | 2017 | 62 | 0.070 |
Why?
|
Animals, Newborn | 3 | 2018 | 178 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2007 | 71 | 0.070 |
Why?
|
Aging | 1 | 2013 | 952 | 0.060 |
Why?
|
Sphingomyelins | 2 | 2020 | 11 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2005 | 23 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2008 | 635 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 50 | 0.060 |
Why?
|
Glucose Transporter Type 1 | 2 | 2002 | 15 | 0.060 |
Why?
|
Fish Oils | 1 | 2005 | 12 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 20 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2017 | 775 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 121 | 0.060 |
Why?
|
Cytochrome P-450 Enzyme Inhibitors | 1 | 2003 | 3 | 0.060 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2003 | 16 | 0.060 |
Why?
|
Carbachol | 2 | 1993 | 18 | 0.060 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 25 | 0.050 |
Why?
|
2-Hydroxypropyl-beta-cyclodextrin | 1 | 2022 | 1 | 0.050 |
Why?
|
Diet | 1 | 2005 | 226 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2003 | 55 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 153 | 0.050 |
Why?
|
Nocodazole | 1 | 2002 | 11 | 0.050 |
Why?
|
Dehydroascorbic Acid | 1 | 2002 | 1 | 0.050 |
Why?
|
Endothelium | 1 | 2002 | 28 | 0.050 |
Why?
|
Adenoviridae | 1 | 2002 | 66 | 0.050 |
Why?
|
Adult | 4 | 2018 | 7506 | 0.050 |
Why?
|
Microtubules | 1 | 2002 | 90 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2012 | 76 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 253 | 0.050 |
Why?
|
Secretory Vesicles | 1 | 2000 | 12 | 0.040 |
Why?
|
Exocytosis | 1 | 2000 | 13 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2012 | 707 | 0.040 |
Why?
|
Desipramine | 1 | 2020 | 4 | 0.040 |
Why?
|
3-O-Methylglucose | 1 | 2000 | 2 | 0.040 |
Why?
|
Galactose | 1 | 2000 | 5 | 0.040 |
Why?
|
Citrate (si)-Synthase | 1 | 2020 | 23 | 0.040 |
Why?
|
Phenotype | 2 | 2012 | 668 | 0.040 |
Why?
|
DNA Probes | 1 | 2000 | 12 | 0.040 |
Why?
|
Rats, Inbred BB | 1 | 2020 | 1 | 0.040 |
Why?
|
Lipogenesis | 1 | 2020 | 29 | 0.040 |
Why?
|
Pregnancy | 2 | 2018 | 1154 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2000 | 150 | 0.040 |
Why?
|
Glomerular Mesangium | 1 | 1999 | 5 | 0.040 |
Why?
|
Time Factors | 2 | 2008 | 1571 | 0.040 |
Why?
|
Protein Kinase C | 1 | 1999 | 72 | 0.040 |
Why?
|
Isoenzymes | 1 | 1999 | 86 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2000 | 247 | 0.040 |
Why?
|
Child, Preschool | 2 | 2012 | 1102 | 0.040 |
Why?
|
Fluorescent Dyes | 2 | 1996 | 89 | 0.040 |
Why?
|
Verrucomicrobia | 1 | 2018 | 1 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2012 | 751 | 0.040 |
Why?
|
Glycerophospholipids | 1 | 2018 | 14 | 0.040 |
Why?
|
Ganglia, Sensory | 1 | 2018 | 3 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2018 | 30 | 0.040 |
Why?
|
Goblet Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
Firmicutes | 1 | 2018 | 15 | 0.040 |
Why?
|
Bacteroidetes | 1 | 2018 | 16 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2018 | 58 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 2018 | 21 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1997 | 10 | 0.040 |
Why?
|
Enzyme Induction | 1 | 1997 | 28 | 0.040 |
Why?
|
Rejuvenation | 1 | 2017 | 26 | 0.040 |
Why?
|
Microorganisms, Genetically-Modified | 1 | 2017 | 1 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 76 | 0.040 |
Why?
|
Administration, Oral | 1 | 2018 | 166 | 0.040 |
Why?
|
Drug Design | 1 | 2018 | 62 | 0.040 |
Why?
|
Survival Analysis | 1 | 2018 | 278 | 0.040 |
Why?
|
Feces | 1 | 2018 | 107 | 0.040 |
Why?
|
Leukocyte Common Antigens | 1 | 2017 | 17 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2017 | 25 | 0.040 |
Why?
|
Hyperplasia | 1 | 2017 | 27 | 0.040 |
Why?
|
Colon | 1 | 2018 | 119 | 0.030 |
Why?
|
Amylases | 2 | 1993 | 4 | 0.030 |
Why?
|
Sincalide | 2 | 1993 | 4 | 0.030 |
Why?
|
Perfusion | 2 | 1993 | 43 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 1997 | 310 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1996 | 30 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 186 | 0.030 |
Why?
|
Femoral Artery | 1 | 2017 | 58 | 0.030 |
Why?
|
Membrane Potentials | 1 | 1996 | 61 | 0.030 |
Why?
|
In Vitro Techniques | 2 | 1993 | 240 | 0.030 |
Why?
|
Oxygen | 1 | 2018 | 230 | 0.030 |
Why?
|
Models, Biological | 2 | 2013 | 448 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 59 | 0.030 |
Why?
|
Child | 2 | 2012 | 2158 | 0.030 |
Why?
|
Action Potentials | 1 | 1996 | 194 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2017 | 455 | 0.030 |
Why?
|
Adolescent | 2 | 2012 | 2993 | 0.030 |
Why?
|
Pyrimidines | 2 | 2006 | 121 | 0.030 |
Why?
|
Alu Elements | 1 | 2013 | 2 | 0.030 |
Why?
|
Herpesvirus 1, Suid | 1 | 2013 | 2 | 0.030 |
Why?
|
Minocycline | 1 | 2013 | 7 | 0.030 |
Why?
|
Procaine | 1 | 1993 | 2 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 2013 | 15 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 13 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2013 | 20 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2013 | 24 | 0.030 |
Why?
|
Electroretinography | 1 | 2014 | 173 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 66 | 0.030 |
Why?
|
Permeability | 1 | 2012 | 59 | 0.030 |
Why?
|
Genetic Markers | 1 | 2012 | 93 | 0.030 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2012 | 1 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 55 | 0.030 |
Why?
|
Histone Demethylases | 1 | 2012 | 9 | 0.030 |
Why?
|
Gestational Age | 1 | 2012 | 141 | 0.020 |
Why?
|
RNA, Long Noncoding | 1 | 2012 | 27 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 60 | 0.020 |
Why?
|
Light Coagulation | 1 | 2011 | 2 | 0.020 |
Why?
|
Adherens Junctions | 1 | 2011 | 8 | 0.020 |
Why?
|
Neurons | 1 | 2013 | 276 | 0.020 |
Why?
|
Lasers | 1 | 2011 | 67 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 472 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 122 | 0.020 |
Why?
|
Biological Transport | 2 | 2002 | 112 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2011 | 408 | 0.020 |
Why?
|
Tumor Burden | 1 | 2010 | 108 | 0.020 |
Why?
|
Scavenger Receptors, Class B | 1 | 2009 | 5 | 0.020 |
Why?
|
Mesenteric Arteries | 1 | 2009 | 8 | 0.020 |
Why?
|
Cytoprotection | 1 | 2009 | 24 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 179 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 656 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2009 | 33 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 66 | 0.020 |
Why?
|
Mesentery | 1 | 2009 | 9 | 0.020 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2009 | 13 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2009 | 25 | 0.020 |
Why?
|
Tosylphenylalanyl Chloromethyl Ketone | 1 | 2008 | 1 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 45 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 28 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 42 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 133 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 50 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 820 | 0.020 |
Why?
|
Astrocytes | 1 | 2009 | 73 | 0.020 |
Why?
|
Vasodilation | 1 | 2009 | 114 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 123 | 0.020 |
Why?
|
Microcirculation | 1 | 2008 | 112 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 446 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2008 | 285 | 0.020 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2006 | 5 | 0.020 |
Why?
|
Mice, Obese | 1 | 2006 | 21 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2006 | 14 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2006 | 17 | 0.020 |
Why?
|
Kinetics | 2 | 2000 | 538 | 0.020 |
Why?
|
PPAR alpha | 1 | 2006 | 32 | 0.020 |
Why?
|
Blood Platelets | 1 | 2008 | 203 | 0.020 |
Why?
|
Sulfonamides | 1 | 2006 | 70 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 811 | 0.020 |
Why?
|
Organ Specificity | 1 | 2005 | 81 | 0.010 |
Why?
|
Insulin | 1 | 2006 | 315 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2003 | 11 | 0.010 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2003 | 4 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 2003 | 12 | 0.010 |
Why?
|
Heterozygote | 1 | 2003 | 64 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 199 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 77 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2003 | 62 | 0.010 |
Why?
|
Nervous System | 1 | 2002 | 12 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2002 | 24 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2002 | 19 | 0.010 |
Why?
|
Microscopy, Interference | 1 | 2000 | 1 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2000 | 18 | 0.010 |
Why?
|
Guinea Pigs | 1 | 2000 | 73 | 0.010 |
Why?
|
Acetylcholine | 1 | 2000 | 73 | 0.010 |
Why?
|
Kidney | 1 | 2002 | 276 | 0.010 |
Why?
|
Protein Kinase C-alpha | 1 | 1999 | 9 | 0.010 |
Why?
|
Scopolamine Derivatives | 1 | 1993 | 1 | 0.010 |
Why?
|
N-Methylscopolamine | 1 | 1993 | 1 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1993 | 9 | 0.010 |
Why?
|
Parasympatholytics | 1 | 1993 | 13 | 0.010 |
Why?
|
Receptors, Cholecystokinin | 1 | 1993 | 5 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1993 | 62 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1993 | 35 | 0.010 |
Why?
|